查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1554230

美國動脈粥狀硬化斑塊切除術設備市場規模、佔有率、趨勢分析報告：按產品類型、應用、最終用途、細分市場預測，2024-2030 年

U.S. Atherectomy Devices Market Size, Share & Trends Analysis Report By Product Type (Directional Atherectomy Systems, Orbital Atherectomy Systems), By Application, By End Use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

美國動脈粥狀硬化斑塊切除術設備市場成長與趨勢

Grand View Research最新報告顯示，到2030年，美國動脈粥狀硬化斑塊切除術設備市場規模預計將達到9.387億美元，2024年至2030年複合年成長率為4.9%。

由於目標疾病盛行率上升和對血管內治療的偏好，預計該區域市場將出現良好成長。此外，對微創手術的需求不斷成長將推動市場成長。與侵入性手術相比，這些手術疼痛更輕，恢復也更快。

此外，由於切口少、術後併發症少、死亡率低等優點，患者滿意度高，也推動了動脈粥狀硬化斑塊切除術設備市場的成長。實現早期診斷的技術進步也可能在不久的將來促進市場成長。例如，2017 年 1 月，Medtronic ) 的 HawkOne定向動脈粥狀硬化斑塊切除術系統獲得 CE 標誌核准，用於治療周邊動脈疾病(PAD) 患者。

美國動脈粥狀硬化斑塊切除術設備市場報告亮點

  • 定向動脈粥狀硬化斑塊切除術系統在市場上佔據主導地位，2023 年市佔率將達到 37.2%。
  • 由於在這種環境下進行了大量的周邊血管介入（PVI）手術，預計辦公室實驗室（OBL）將成為預測期內成長最快的部分。
  • 此外，更少的併發症和後續觀察可以降低成本並增加新技術的採用，從而帶來更好的健康結果。
  • 正在進行的多項臨床試驗及其積極結果將加速新技術的滲透。例如，雅培 (Abbott) 於 2023 年 4 月收購了醫療設備製造商心血管系統公司 (CSI)，增強了其治療周邊動脈和冠狀動脈疾病患者的能力。
  • 主要企業包括 Abbott、Boston Scientific、B.Braun SE、AngioDynamics、Terumo Medical Corp、Cardioangio Systems, Inc、Medtronic PLC、Avinger, Inc、ST.JUDE MEDICAL, Inc。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章美國動脈粥狀硬化斑塊切除術設備市場變數、趨勢、範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國動脈粥狀硬化斑塊切除術設備市場分析工具
    • 波特的分析
    • PESTEL分析

第4章美國動脈粥狀硬化斑塊切除術設備市場：依產品估算與趨勢分析

  • 細分儀表板
  • 美國動脈粥狀硬化斑塊切除術設備市場：2023 年和 2030 年產品變化分析
  • 定向動脈粥狀硬化斑塊切除術系統
  • 眼眶動脈粥狀硬化斑塊切除術系統
  • 光學消融（雷射）動脈粥狀硬化斑塊切除術系統
  • 旋轉斑塊動脈粥狀硬化斑塊切除術系統

第5章美國動脈粥狀硬化斑塊切除術設備市場：按應用估計和趨勢分析

  • 細分儀表板
  • 美國動脈粥狀硬化斑塊切除術設備市場：2023 年和 2030 年應用變化分析
  • 周圍血管
  • 神經血管的
  • 心血管

第6章美國動脈粥狀硬化斑塊切除術設備市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 美國動脈粥狀硬化斑塊切除術設備市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 門診治療中心
  • 其他

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Abbott
    • B. Braun SE
    • Boston Scientific Corporation
    • BD
    • AngioDynamics Inc.
    • Biomerics LLC
    • Terumo Corporation
    • Medtronic
    • Koninklijke Philips NV
簡介目錄
Product Code: GVR-2-68038-799-5

U.S. Atherectomy Devices Market Growth & Trends:

The U.S. atherectomy devices market size is expected to reach USD 938.7 million by 2030, expanding at a CAGR of 4.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The regional market is expected to witness lucrative growth due to the rising prevalence of target diseases and preference for endovascular procedures. Moreover, rising demand for minimally invasive procedure will boost the market growth. Such procedures are less painful and allow quicker recovery than invasive procedures.

Other advantages, such as higher patient satisfaction owing to fewer incision wounds, few post-surgical complications, and low mortality rates, are also driving the atherectomy devices market growth. Technological advancements allowing early diagnosis are also likely to augment the market growth in the near future. For instance, in January 2017, Medtronic received CE mark approval for HawkOne directional atherectomy system for treating patients suffering from Peripheral Artery Disease (PAD).

U.S. Atherectomy Devices Market Report Highlights:

  • Directional atherectomy systems dominated the market and accounted for a share of 37.2% in 2023.
  • Office-Based Labs (OBLs) is anticipated to be the fastest-growing segment in the forecast period due to a greater number of Peripheral Vascular Interventional (PVI) procedures being performed in this setting
  • In addition, lesser number of complications and follow-up procedures lowers the cost and increases the adoption of new technologies delivering better health outcomes, which is anticipated to propel the market growth in the coming years
  • Several ongoing trials and their positive results facilitate penetration of novel technologies. For instance, Abbott acquired the medical device company Cardiovascular Systems, Inc. (CSI) in April 2023 to enhance its capabilities to treat patients with peripheral and coronary diseases.
  • Some of the key companies are Abbott; Boston Scientific Corp.;B. Braun SE; AngioDynamics; Terumo Medical Corp.; Cardiovascular Systems, Inc.; Medtronic PLC; Avinger, Inc.; ST. JUDE MEDICAL, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Atherectomy Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. Atherectomy Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. Atherectomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Atherectomy Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Directional Atherectomy Systems
    • 4.3.1. Directional Atherectomy Systems Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Orbital Atherectomy Systems
    • 4.4.1. Orbital Atherectomy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Photo-ablative (Laser) Atherectomy Systems
    • 4.5.1. Photo-ablative (Laser) Atherectomy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Rotational Atherectomy Systems
    • 4.6.1. Rotational Atherectomy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Atherectomy Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Atherectomy Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Peripheral Vascular
    • 5.3.1. Peripheral Vascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Neurovascular
    • 5.4.1. Neurovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular
    • 5.5.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Atherectomy Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Atherectomy Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Ambulatory Care Centers
    • 6.4.1. Ambulatory Care Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. B. Braun SE
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Boston Scientific Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. BD
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. AngioDynamics Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Biomerics LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Terumo Corporation
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Medtronic
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Koninklijke Philips NV
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives